DIF inhibitors (Biota)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameDIF inhibitors (Biota)
Drug Alias Nameantibacterial (Prolysis)antibacterial (Biota Scientific Management)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProlysis Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A